speb/financial-data huggingface dataset:
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 6426800000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 7808700000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 206800000.00
PANACEABIO.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -113900000.00
PANACEABIO.NS income_statement (quarterly, 2025-09-30) — Normalized Income: -158932394.37
PANACEABIO.NS income_statement (quarterly, 2025-09-30) — Operating Income: -261300000.00
PANACEABIO.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 1411300000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 61250746.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 1301100000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 1128400000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 8202800000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 455400000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 11900000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 53400000.00
PANACEABIO.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 64000000.00
PANACEABIO.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 522700000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 5328500000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 29700000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 646800000.00
PANACEABIO.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Payables: 1853300000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 353900000.00
PANACEABIO.NS income_statement (quarterly, 2025-09-30) — Pretax Income: -191700000.00
PANACEABIO.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 589400000.00
PANACEABIO.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 83400000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 61250746.00
PANACEABIO.NS income_statement (quarterly, 2025-09-30) — Special Income Charges: 27000000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 8264100000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 7808700000.00
PANACEABIO.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 7267605.63
PANACEABIO.NS income_statement (quarterly, 2025-09-30) — Tax Provision: -51600000.00
PANACEABIO.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.27
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 12545000000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 8493100000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 229000000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 8220600000.00
PANACEABIO.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 1672600000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 4324400000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 7215200000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 873600000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 400000.00
PANACEABIO.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items: 27000000.00
PANACEABIO.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 27000000.00
PANACEABIO.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 1879000000.00
PANACEABIO.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 939700000.00
PANACEABIO.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 1651900000.00
PANACEABIO.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 61230769.00
PANACEABIO.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 0.65
PANACEABIO.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 679300000.00
PANACEABIO.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 84500000.00
PANACEABIO.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 84500000.00
PANACEABIO.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 61230769.00
PANACEABIO.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.65
PANACEABIO.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 39800000.00
PANACEABIO.NS income_statement (quarterly, 2025-12-31) — EBIT: 83400000.00
PANACEABIO.NS income_statement (quarterly, 2025-12-31) — EBITDA: 167900000.00
PANACEABIO.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 972600000.00
PANACEABIO.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 18500000.00
PANACEABIO.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 18500000.00
PANACEABIO.NS income_statement (quarterly, 2025-12-31) — Minority Interests: 900000.00
PANACEABIO.NS income_statement (quarterly, 2025-12-31) — Net Income: 39800000.00
PANACEABIO.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 39800000.00
PANACEABIO.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 38900000.00
PANACEABIO.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 39800000.00
PANACEABIO.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 39800000.00
PANACEABIO.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 38900000.00
PANACEABIO.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -18500000.00
PANACEABIO.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -18500000.00
PANACEABIO.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 140200000.00
PANACEABIO.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 20410000.00
PANACEABIO.NS income_statement (quarterly, 2025-12-31) — Operating Income: 32900000.00
PANACEABIO.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 1651900000.00
PANACEABIO.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 22800000.00
PANACEABIO.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 449900000.00
PANACEABIO.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
PANACEABIO.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 64900000.00
PANACEABIO.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 679300000.00
PANACEABIO.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 84500000.00
PANACEABIO.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: 27700000.00
PANACEABIO.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 8310000.00
PANACEABIO.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 26000000.00
PANACEABIO.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.30
PANACEABIO.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 1619000000.00
PANACEABIO.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: 27700000.00
PANACEABIO.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 27700000.00
PANACEABIO.NS income_statement (annual, 2026-03-31) — +Operating Expense: 3970100000.00
PANACEABIO.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 956700000.00
PANACEABIO.NS income_statement (annual, 2026-03-31) — +Total Revenue: 6397700000.00
PANACEABIO.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 1667500000.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 1896000000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 1896000000.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 735200000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 735200000.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 120300000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 120300000.00
PANACEABIO.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 65000000.00
PANACEABIO.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 0.08
PANACEABIO.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 821300000.00
PANACEABIO.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -540900000.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 61300000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 61300000.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 573100000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 573100000.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 1346600000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 1346600000.00
PANACEABIO.NS cash_flow (annual, 2026-03-31) — Change In Inventory: 208800000.00
PANACEABIO.NS cash_flow (annual, 2026-03-31) — Change In Receivables: 120100000.00
PANACEABIO.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: 139700000.00
PANACEABIO.NS cash_flow (annual, 2026-03-31) — Changes In Cash: -248600000.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Common Stock: 61300000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 61300000.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 8348400000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 8348400000.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 999700000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 999700000.00
PANACEABIO.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 2804800000.00
PANACEABIO.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 763900000.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Current Assets: 5130400000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 5130400000.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Current Debt: 0.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 0.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 0.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 0.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 3486800000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 3486800000.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 394800000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 394800000.00
PANACEABIO.NS cash_flow (annual, 2026-03-31) — Depreciation: 330600000.00
PANACEABIO.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 330600000.00
PANACEABIO.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 330600000.00
PANACEABIO.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 78800000.00
PANACEABIO.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 330600000.00
PANACEABIO.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 78800000.00
PANACEABIO.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 65000000.00
PANACEABIO.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.08
PANACEABIO.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: -53700000.00
PANACEABIO.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 5200000.00
PANACEABIO.NS cash_flow (annual, 2026-03-31) — Dividends Received Cfi: 0.00
PANACEABIO.NS income_statement (annual, 2026-03-31) — EBIT: -13200000.00
PANACEABIO.NS income_statement (quarterly, 2026-03-31) — EBIT: -500000.00
PANACEABIO.NS income_statement (annual, 2026-03-31) — EBITDA: 317400000.00
PANACEABIO.NS income_statement (quarterly, 2026-03-31) — EBITDA: 78300000.00
PANACEABIO.NS cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: 400000.00
PANACEABIO.NS cash_flow (annual, 2026-03-31) — End Cash Position: 573100000.00
PANACEABIO.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: -10500000.00
PANACEABIO.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: -374100000.00
PANACEABIO.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -9500000.00
PANACEABIO.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: 0.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 508900000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 508900000.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 6532400000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 6532400000.00
PANACEABIO.NS income_statement (annual, 2026-03-31) — Gross Profit: 3592900000.00
PANACEABIO.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 903600000.00
PANACEABIO.NS income_statement (annual, 2026-03-31) — Interest Expense: 60500000.00
PANACEABIO.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 12000000.00
PANACEABIO.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 60500000.00
PANACEABIO.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 12000000.00
PANACEABIO.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -44200000.00
PANACEABIO.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 41600000.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Inventory: 1927900000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 1927900000.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 8585000000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 8585000000.00
PANACEABIO.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -404900000.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Investment Properties: 155000000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Investment Properties: 155000000.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 120300000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 120300000.00
PANACEABIO.NS cash_flow (annual, 2026-03-31) — Issuance Of Debt: 0.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 236600000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 236600000.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 236600000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 236600000.00
PANACEABIO.NS cash_flow (annual, 2026-03-31) — Long Term Debt Issuance: 0.00
PANACEABIO.NS cash_flow (annual, 2026-03-31) — Long Term Debt Payments: 0.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 366200000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 366200000.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Minority Interest: -59600000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Minority Interest: -59600000.00
PANACEABIO.NS income_statement (annual, 2026-03-31) — Minority Interests: 17900000.00
PANACEABIO.NS income_statement (quarterly, 2026-03-31) — Minority Interests: 15200000.00
PANACEABIO.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 53300000.00
PANACEABIO.NS income_statement (annual, 2026-03-31) — Net Income: -53700000.00
PANACEABIO.NS income_statement (quarterly, 2026-03-31) — Net Income: 5200000.00
PANACEABIO.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: -53700000.00
PANACEABIO.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 5200000.00
PANACEABIO.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: -71600000.00
PANACEABIO.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -10000000.00
PANACEABIO.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -53700000.00
PANACEABIO.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 5200000.00
PANACEABIO.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -53700000.00
PANACEABIO.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 5200000.00
PANACEABIO.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: -73700000.00
PANACEABIO.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: -71600000.00
PANACEABIO.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -10000000.00
PANACEABIO.NS income_statement (annual, 2026-03-31) — Net Interest Income: -60500000.00
PANACEABIO.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -12000000.00
PANACEABIO.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: 74000000.00
PANACEABIO.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 0.00
PANACEABIO.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 0.00
PANACEABIO.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -60500000.00
PANACEABIO.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -12000000.00
PANACEABIO.NS cash_flow (annual, 2026-03-31) — Net Other Financing Charges: 33700000.00
PANACEABIO.NS cash_flow (annual, 2026-03-31) — Net Other Investing Changes: 20400000.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Net PPE: 6532400000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 6532400000.00
PANACEABIO.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -540900000.00
PANACEABIO.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: 0.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 7839500000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 7839500000.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 231400000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 231400000.00
PANACEABIO.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 122400000.00
PANACEABIO.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 51200000.00
PANACEABIO.NS income_statement (annual, 2026-03-31) — Normalized Income: -243143690.64
PANACEABIO.NS income_statement (quarterly, 2026-03-31) — Normalized Income: -16480000.00
PANACEABIO.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 166800000.00
PANACEABIO.NS income_statement (annual, 2026-03-31) — Operating Income: -377200000.00
PANACEABIO.NS income_statement (quarterly, 2026-03-31) — Operating Income: -53100000.00
PANACEABIO.NS income_statement (annual, 2026-03-31) — Operating Revenue: 6397700000.00
PANACEABIO.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 1667500000.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 61250746.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 61250746.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 1101300000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 1101300000.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 1075300000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 1075300000.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 8287100000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 8287100000.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 508900000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 508900000.00
PANACEABIO.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: -245600000.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 12200000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 12200000.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: 7300000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 7300000.00
PANACEABIO.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 169000000.00
PANACEABIO.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 25500000.00
PANACEABIO.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 1831700000.00
PANACEABIO.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 409700000.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Other Properties: 5532700000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 5532700000.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 19400000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 19400000.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 773500000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 773500000.00
PANACEABIO.NS income_statement (annual, 2026-03-31) — Other Special Charges: -195000000.00
PANACEABIO.NS income_statement (quarterly, 2026-03-31) — Other Special Charges: -27100000.00
PANACEABIO.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
PANACEABIO.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Payables: 1916300000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Payables: 1916300000.00
PANACEABIO.NS income_statement (annual, 2026-03-31) — Pretax Income: -73700000.00
PANACEABIO.NS income_statement (quarterly, 2026-03-31) — Pretax Income: -12500000.00
PANACEABIO.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: 35200000.00
PANACEABIO.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -3472000000.00
PANACEABIO.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -540900000.00
PANACEABIO.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 2804800000.00
PANACEABIO.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 763900000.00
PANACEABIO.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 330600000.00
PANACEABIO.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 78800000.00
PANACEABIO.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: 0.00
PANACEABIO.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 3546000000.00
PANACEABIO.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 0.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Share Issued: 61250746.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 61250746.00
PANACEABIO.NS cash_flow (annual, 2026-03-31) — Short Term Debt Issuance: 0.00
PANACEABIO.NS cash_flow (annual, 2026-03-31) — Short Term Debt Payments: 0.00
PANACEABIO.NS income_statement (annual, 2026-03-31) — Special Income Charges: 195000000.00
PANACEABIO.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 27100000.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 8348400000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 8348400000.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 7839500000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 7839500000.00
PANACEABIO.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 5556309.36
PANACEABIO.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 5420000.00
PANACEABIO.NS income_statement (annual, 2026-03-31) — Tax Provision: -2100000.00
PANACEABIO.NS income_statement (quarterly, 2026-03-31) — Tax Provision: -2500000.00
PANACEABIO.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.03
PANACEABIO.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.20
PANACEABIO.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -64500000.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Total Assets: 12621700000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 12621700000.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 8585000000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 8585000000.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Total Debt: 236600000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 236600000.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 8288800000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 8288800000.00
PANACEABIO.NS income_statement (annual, 2026-03-31) — Total Expenses: 6774900000.00
PANACEABIO.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 1720600000.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 4332900000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 4332900000.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 7491300000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 7491300000.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 846100000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 846100000.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 20300000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 20300000.00
PANACEABIO.NS income_statement (annual, 2026-03-31) — Total Unusual Items: 195000000.00
PANACEABIO.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 27100000.00
PANACEABIO.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: 195000000.00
PANACEABIO.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 27100000.00
PANACEABIO.NS balance_sheet (annual, 2026-03-31) — Working Capital: 1643600000.00
PANACEABIO.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 1643600000.00
PANACHE.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -36438000.00
PANACHE.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 67800000.00
PANACHE.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -1343000.00
PANACHE.NS income_statement (annual, 2022-03-31) — Amortization: 11000.00
PANACHE.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 51803000.00
PANACHE.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 8140000.00
PANACHE.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 920000.00
PANACHE.NS cash_flow (annual, 2022-03-31) — Deferred Tax: 130000.00
PANACHE.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 8000.00
PANACHE.NS balance_sheet (annual, 2022-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 0.00
PANACHE.NS cash_flow (annual, 2022-03-31) — Gain Loss On Investment Securities: -357000.00
PANACHE.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 8403000.00
PANACHE.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 316522000.00
PANACHE.NS income_statement (annual, 2022-03-31) — Interest Income: 15750000.00
PANACHE.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 15750000.00
PANACHE.NS balance_sheet (annual, 2022-03-31) — Investmentsin Associatesat Cost: 60000.00
PANACHE.NS balance_sheet (annual, 2022-03-31) — Investmentsin Joint Venturesat Cost: 60000.00
PANACHE.NS cash_flow (annual, 2022-03-31) — Long Term Debt Issuance: 25000000.00
PANACHE.NS cash_flow (annual, 2022-03-31) — Long Term Debt Payments: -42591000.00
PANACHE.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 21936000.00
PANACHE.NS income_statement (annual, 2022-03-31) — Minority Interests: 0.00
PANACHE.NS income_statement (annual, 2022-03-31) — Net Income Extraordinary: 43000.00
PANACHE.NS cash_flow (annual, 2022-03-31) — Net Long Term Debt Issuance: -17591000.00
PANACHE.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Revenue: 60000.00
PANACHE.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 6689000.00
PANACHE.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 1793000.00
PANACHE.NS balance_sheet (annual, 2022-03-31) — Ordinary Shares Number: 12000000.00
PANACHE.NS balance_sheet (annual, 2022-03-31) — Other Payable: 16662000.00
PANACHE.NS income_statement (annual, 2022-03-31) — Other Special Charges: 1434000.00
PANACHE.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 841000.00
PANACHE.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 65638000.00
PANACHE.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
PANACHE.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 257000.00
PANACHE.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 257000.00
PANACHE.NS income_statement (annual, 2022-03-31) — Research And Development: 0.00
PANACHE.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 8000.00
PANACHE.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 115223000.00
PANACHE.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 2070000.00
PANACHE.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 10473000.00
PANACHE.NS balance_sheet (annual, 2022-03-31) — Share Issued: 12000000.00
PANACHE.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 2582000.00
PANACHE.NS balance_sheet (annual, 2022-03-31) — Tradeand Other Payables Non Current: 60000.00
PANACHE.NS income_statement (annual, 2022-03-31) — Write Off: 1512000.00
PANACHE.NS income_statement (annual, 2023-03-31) — +Operating Expense: 75634000.00
PANACHE.NS income_statement (annual, 2023-03-31) — +Total Revenue: 1117961000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 194103000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 479435000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -19130000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 67800000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -1091000.00
PANACHE.NS income_statement (annual, 2023-03-31) — Amortization: 0.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 0.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Assets Held For Sale Current: 113092000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 25000.00
PANACHE.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 12000000.00
PANACHE.NS income_statement (annual, 2023-03-31) — Basic EPS: 0.69
PANACHE.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: -124528000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 81591000.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -11154000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 11465000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 120000000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 2327000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 2327000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 1663000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 664000.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Change In Inventory: 7920000.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: 43817000.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: -53208000.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Change In Payable: 48290000.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -166007000.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -120047000.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Changes In Cash: -158992000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Common Stock: 120000000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 314424000.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Common Stock Issuance: 0.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 0.00
PANACHE.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 989869000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Current Assets: 901913000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 3703000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Current Debt: 310724000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 314427000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 659347000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 4075000.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Depreciation: 7910000.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 7910000.00
PANACHE.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 7909000.00
PANACHE.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 7909000.00
PANACHE.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 12000000.00
PANACHE.NS income_statement (annual, 2023-03-31) — Diluted EPS: 0.69
PANACHE.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 8241000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 8000.00
PANACHE.NS income_statement (annual, 2023-03-31) — EBIT: 55779000.00
PANACHE.NS income_statement (annual, 2023-03-31) — EBITDA: 63689000.00
PANACHE.NS cash_flow (annual, 2023-03-31) — End Cash Position: -283521000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 0.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -150327000.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: -77228000.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -350000.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: -6910000.00
PANACHE.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 8408000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Goodwill: 0.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 0.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 480526000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 113106000.00
PANACHE.NS income_statement (annual, 2023-03-31) — Gross Profit: 128092000.00
PANACHE.NS income_statement (annual, 2023-03-31) — Interest Expense: 37993000.00
PANACHE.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 37993000.00
PANACHE.NS income_statement (annual, 2023-03-31) — Interest Income: 3617000.00
PANACHE.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 3617000.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -47464000.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 1092000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Inventory: 255573000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 656383000.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: 57409000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Investment Properties: 23490000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 0.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Investmentsin Associatesat Cost: 8000.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 0.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 0.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 7762000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 31235000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 38997000.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 0.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -43145000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 8000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 6380000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 29919000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Minority Interest: 0.00
PANACHE.NS income_statement (annual, 2023-03-31) — Minority Interests: 0.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 0.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Net Debt: 339632000.00
PANACHE.NS income_statement (annual, 2023-03-31) — Net Income: 8241000.00
PANACHE.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 8241000.00
PANACHE.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 13131000.00
PANACHE.NS income_statement (annual, 2023-03-31) — Net Income Discontinuous Operations: -4890000.00
PANACHE.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 8241000.00
PANACHE.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 13131000.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 12896000.00
PANACHE.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 8241000.00
PANACHE.NS income_statement (annual, 2023-03-31) — Net Interest Income: -36362000.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 0.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: -97213000.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: -43145000.00
PANACHE.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -36362000.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Net Other Financing Charges: -1277000.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: 1511000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Net PPE: 93976000.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: 54806000.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: -54068000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 314424000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Revenue: 60000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 0.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 1093000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 6380000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 1904000.00
PANACHE.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 63844000.00
PANACHE.NS income_statement (annual, 2023-03-31) — Normalized Income: 13247498.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: -66074000.00
PANACHE.NS income_statement (annual, 2023-03-31) — Operating Income: 52458000.00
PANACHE.NS income_statement (annual, 2023-03-31) — Operating Revenue: 1117961000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 12000000.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Other Cash Adjustment Outside Changein Cash: -1000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 8756000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 8026000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 194423000.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 47522000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 39000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: -1000.00
PANACHE.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 5243000.00
PANACHE.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 11626000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Other Payable: 7539000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Other Properties: 1596000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 1120000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 8000.00
PANACHE.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Payables: 205601000.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Pension And Employee Benefit Expense: 660000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 458000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 20601000.00
PANACHE.NS income_statement (annual, 2023-03-31) — Pretax Income: 17786000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 1367600.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: 0.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -11154000.00
PANACHE.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 989869000.00
PANACHE.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 7910000.00
PANACHE.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 342000.00
PANACHE.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 342000.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: -97213000.00
PANACHE.NS income_statement (annual, 2023-03-31) — Research And Development: 0.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 8000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 123465000.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 0.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 65960000.00
PANACHE.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 1175000.00
PANACHE.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 9583000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Share Issued: 12000000.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Short Term Debt Issuance: 0.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Short Term Debt Payments: -54068000.00
PANACHE.NS income_statement (annual, 2023-03-31) — Special Income Charges: -155000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 314424000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 314424000.00
PANACHE.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: -38502.00
PANACHE.NS income_statement (annual, 2023-03-31) — Tax Provision: 4602000.00
PANACHE.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.25
PANACHE.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 21001000.00
PANACHE.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -9281000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Total Assets: 1021355000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 345659000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Total Debt: 353424000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 314424000.00
PANACHE.NS income_statement (annual, 2023-03-31) — Total Expenses: 1065503000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 706931000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 119442000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 47584000.00
PANACHE.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 1986000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 3951000.00
PANACHE.NS income_statement (annual, 2023-03-31) — Total Unusual Items: -155000.00
PANACHE.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: -155000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Tradeand Other Payables Non Current: 235000.00
PANACHE.NS balance_sheet (annual, 2023-03-31) — Working Capital: 242566000.00
PANACHE.NS income_statement (annual, 2023-03-31) — Write Off: 155000.00
PANACHE.NS income_statement (annual, 2024-03-31) — +Operating Expense: 86438000.00
PANACHE.NS income_statement (annual, 2024-03-31) — +Total Revenue: 965425000.00
PANACHE.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 247909000.00
PANACHE.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 477102000.00
PANACHE.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -27153000.00
PANACHE.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 67800000.00
PANACHE.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -561000.00
PANACHE.NS income_statement (annual, 2024-03-31) — Amortization: 8000.00
PANACHE.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 8000.00
PANACHE.NS balance_sheet (annual, 2024-03-31) — Assets Held For Sale Current: 39108000.00
PANACHE.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 748400.00
PANACHE.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 12000000.00
PANACHE.NS income_statement (annual, 2024-03-31) — Basic EPS: 0.46
PANACHE.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: -283521000.00
PANACHE.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 81591000.00
PANACHE.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -6675000.00
PANACHE.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 7762000.00
PANACHE.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 120000000.00
PANACHE.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 5939000.00
PANACHE.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 5939000.00
PANACHE.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 5195000.00
PANACHE.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 744000.00
PANACHE.NS cash_flow (annual, 2024-03-31) — Change In Inventory: 3477000.00
PANACHE.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: -12240000.00
PANACHE.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: -39526000.00
PANACHE.NS cash_flow (annual, 2024-03-31) — Change In Payable: 50062000.00
PANACHE.NS cash_flow (annual, 2024-03-31) — Change In Receivables: 4471000.00
PANACHE.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: 7572000.00
PANACHE.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 10243000.00
PANACHE.NS balance_sheet (annual, 2024-03-31) — Common Stock: 120000000.00